Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.

Dapp MJ, Clouser CL, Patterson S, Mansky LM.

J Virol. 2009 Nov;83(22):11950-8. doi: 10.1128/JVI.01406-09. Epub 2009 Sep 2.

PMID:
19726509
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1.

Dapp MJ, Bonnac L, Patterson SE, Mansky LM.

J Virol. 2014 Jan;88(1):354-63. doi: 10.1128/JVI.02444-13. Epub 2013 Oct 23.

PMID:
24155391
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Concomitant lethal mutagenesis of human immunodeficiency virus type 1.

Dapp MJ, Holtz CM, Mansky LM.

J Mol Biol. 2012 Jun 8;419(3-4):158-70. doi: 10.1016/j.jmb.2012.03.003. Epub 2012 Mar 15.

PMID:
22426127
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.

Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM.

Bioorg Med Chem. 2013 Nov 15;21(22):7222-8. doi: 10.1016/j.bmc.2013.08.023. Epub 2013 Aug 20.

PMID:
24120088
[PubMed - indexed for MEDLINE]
5.

5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro.

Bouchard J, Walker MC, Leclerc JM, Lapointe N, Beaulieu R, Thibodeau L.

Antimicrob Agents Chemother. 1990 Feb;34(2):206-9.

PMID:
1691617
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.

Turpin JA, Buckheit RW Jr, Derse D, Hollingshead M, Williamson K, Palamone C, Osterling MC, Hill SA, Graham L, Schaeffer CA, Bu M, Huang M, Cholody WM, Michejda CJ, Rice WG.

Antimicrob Agents Chemother. 1998 Mar;42(3):487-94.

PMID:
9517921
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Lethal mutagenesis of HIV with mutagenic nucleoside analogs.

Loeb LA, Essigmann JM, Kazazi F, Zhang J, Rose KD, Mullins JI.

Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1492-7.

PMID:
9990051
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.

Nikolenko GN, Svarovskaia ES, Delviks KA, Pathak VK.

J Virol. 2004 Aug;78(16):8761-70.

PMID:
15280484
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.

Korth MJ, Taylor MD, Katze MG.

Virology. 1998 Aug 1;247(2):265-73.

PMID:
9705919
[PubMed - indexed for MEDLINE]
Free Article
11.

The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.

Gerondelis P, Archer RH, Palaniappan C, Reichman RC, Fay PJ, Bambara RA, Demeter LM.

J Virol. 1999 Jul;73(7):5803-13.

PMID:
10364332
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
14.

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E, et al.

J Virol. 1995 Feb;69(2):814-24.

PMID:
7815548
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.

Hamasaki T, Okamoto M, Baba M.

Antimicrob Agents Chemother. 2013 Mar;57(3):1323-31. doi: 10.1128/AAC.01711-12. Epub 2012 Dec 28.

PMID:
23274668
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mechanism of inhibitory effect of NCC164 on replication of human immunodeficiency virus.

Nakamura M, Terada M, Matsuzaki K, Yoshida K, Ohno T.

Microbiol Immunol. 2001;45(3):217-23.

PMID:
11345531
[PubMed - indexed for MEDLINE]
17.

Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef.

Ptak RG, Gentry BG, Hartman TL, Watson KM, Osterling MC, Buckheit RW Jr, Townsend LB, Drach JC.

Antimicrob Agents Chemother. 2010 Apr;54(4):1512-9. doi: 10.1128/AAC.01443-09. Epub 2010 Jan 19.

PMID:
20086149
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.

Kortagere S, Madani N, Mankowski MK, Schön A, Zentner I, Swaminathan G, Princiotto A, Anthony K, Oza A, Sierra LJ, Passic SR, Wang X, Jones DM, Stavale E, Krebs FC, Martín-García J, Freire E, Ptak RG, Sodroski J, Cocklin S, Smith AB 3rd.

J Virol. 2012 Aug;86(16):8472-81. doi: 10.1128/JVI.05006-11. Epub 2012 May 30.

PMID:
22647699
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1).

Pereira HS, Leão-Ferreira LR, Moussatché N, Teixeira VL, Cavalcanti DN, Costa LJ, Diaz R, Frugulhetti IC.

Antiviral Res. 2004 Oct;64(1):69-76.

PMID:
15451181
[PubMed - indexed for MEDLINE]
20.

A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.

Druillennec S, Dong CZ, Escaich S, Gresh N, Bousseau A, Roques BP, Fournié-Zaluski MC.

Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4886-91.

PMID:
10220388
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk